Perficient is a leading digital transformation consulting firm that provides services to Global 2000 companies including information technology, management consulting, and creative capabilities. It delivers vision, execution, and value through outstanding digital experiences, business optimization, and industry solutions. The document discusses several trends in healthcare and clinical trials, including employing mobile applications in research, investing in social listening tools, and keeping clinical trial data secure.

1. EMPLOYING MOBILEAPPLICATIONS IN RESEARCH
INVESTING IN SOCIAL LISTENINGTOOLS
BLOGS.PERFICIENT.COM TWITTER.COM/PERFICIENT FACEBOOK.COM/PERFICIENT PERFICIENT.COM/WHITEPAPERS
Perficient is the leading digital transformation consulting firm serving Global 2000® and enterprise customers
throughout North America. With unparalleled information technology, management consulting and creative
capabilities, Perficient delivers vision, execution and value with outstanding digital experience, business
optimization and industry solutions.
SOURCES:
https://www.youtube.com/watch?v=v6b7XgaOIxk
http://www.clinicalleader.com/doc/can-electronic-health-records-bring-
down-drug-prices-0001
http://techcrunch.com/2015/10/08/mobile-searches-surpass-desktop-s
earches-at-google-for-the-first-time/
http://www.theverge.com/2015/10/8/9480779/google-search-mobile-v
s-desktop-2015
https://treato.com/articles/The_Kim_Kardashian_Effect/
http://www.boozallen.com/media-center/press-releases/2015/12/booz-
allen-forecasts-hottest-technology-trends-that-will-dominat
http://insight.venturebeat.com/state-of-marketing-technology-hyper-pe
rsonalization
http://www.proteus.com/company/mission/
http://www.fiercebiotechit.com/story/analyst-use-tech-streamline-clini
cal-trials-still-early-its-adoption-cycle/2015-12-14
http://blogs.perficient.com/lifesciences/2015/09/18/why-clinical-trial-da
ta-isnt-enough/
https://www.youtube.com/watch?v=Zj_EM1VBMDg
http://www.prnewswire.com/news-releases/clinical-trial-results-disclo
sure-by-large-biopharmaceutical-companies-falls-below-legal-and-ethic
al-standards-study-published-in-bmj-open-shows-300177078.html
http://www.securingindustry.com/pharmaceuticals/survey-reveals-dat
a-breaches-hitting-pharma-industry/s40/a2500/#.VowP2_krKM8
http://us.boehringer-ingelheim.com/news_events/press_releases/pres
s_release_archive/2015/11-9-2015-real-world-analysis-more-than-4400
0-patients-reinforces-safety-effectiveness-pradaxa-dabigatran-etexilate
-mesylate-routine-clinical-care.html
http://www.statnews.com/2015/12/13/clinical-trials-investigation/
http://www.businesswire.com/news/home/20150910005111/en/ICO
N-IBM-Revolutionise-Clinical-Trial-Feasibility-Patient
http://www.thepharmaletter.com/article/protocol-amendments-improv
e-elements-of-clinical-trial-feasibility-but-at-what-cost-tufts-csdd
10LIFESCIENCES
CREATIVE FORMS OF SUBJECT RECRUITMENT
USING EHR DATATO DETERMINE SITE/STUDY FEASIBILITY
>$1.2 BILLION
COST PER AMENDMENT
ONLY 5%
of cancer patients ever enroll in a trial,
according to Dr. Steven Alberts, Chair of
Medical Oncology with the Mayo Clinic
By evaluating certain criteria against
patient populations, electronic health
record (EHR) systems can help sponsors
determine trial feasibility and shape better
study protocols
is spent on patient recruitment each year
>30%
of total study costs goes towards
recruiting the required number of
patients for clinical trials
of "digital natives," or those
who grew up with the web,
expect a personalized
website experience
Kim Kardashian's
Instagram posts boosted
the conversation around
Diclegis®, Duchesnay
Pharma’s medication for
morning sickness, by
500%
50%of prescription medicine
is not taken as directed,
which can worsen
medical conditions and
increase healthcare costs
10%
of clinical trials are currently using RBM
Real-world analysis of
> 44,000patients reinforces safety
and effectiveness of
Boehringer Ingelheim's
Pradaxa® in routine
clinical care
2
3
4
5
6
7
8
$300K
to
$500K
to start up a global Phase III drug trial, with
another 12 months necessary to enroll patients
of all clinical trial protocols need at least
one substantial global amendment60%
of Google’s 100 billion monthly searches occur on mobile devices
MORE THAN HALF
6-12 MONTHS
In 2015 more Google
searches were completed
on mobile devices than
desktop computers
MAKING EACH POINT OF INTERACTION HYPER-PERSONALIZED
NEWTECHNOLOGIESWILL IMPROVE MEDICATIONADHERENCE
DEPLOYING RISK-BASED MONITORING (RBM) STRATEGIES
LEVERAGING REAL-WORLD DATATO DEVELOP
BETTER DRUG PROFILES
9
“Advanced analytics will enable organizations
to achieve an unprecedented, 360-degree view
understanding of their customers – on a highly
individualized basis.”
- Booz Allen Hamilton
1
TRANSPARENCY IN CLINICALTRIALSAND OPERATIONS
10
KEEPING DATA SECURE
In one study, academic
institutions reported clinical
trial results late or not at all
90%of the time, while product
manufacturers performed
slightly better at
74%
66%
25%
were specifically
hacked, some
multiple times
of pharmaceutical
companies have
suffered serious
data breaches
12%
Only 66% of clinical trials that
supported new drug approvals in 2012
were disclosed, falling below legal and
ethical standards
Although specific
trials and types of
products are excluded, current regulations
require study sponsors to submit clinical trial
results within 12 months after reaching the
trial’s completion date, or within 30 days of
FDA approval. While the FDA has the ability to
levy penalties of up to $10,000 a day per trial, it
has yet to take action.
of firms have been victims of
cyber attacks between seven
and nine times 8% have been attacked
13 to 15 times
TRENDS